Ripple’s ongoing battle with the SEC isn’t stopping the blockchain payments company from carving out a stronger position in the market.

Ripple, SEC, Funding, Venture CapitalRead More

You might also be interested in reading Alkermes anticipates record proprietary product sales above $1B for 2025 as orexin pipeline advances.